_PRIVATE_LIMITED.webp)
Carewin Pharmaceuticals (Gujarat) Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 11-12-2024
- Paid Up Capital ₹ 1.94 M
as on 11-12-2024
- Company Age 29 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.30 Cr
as on 11-12-2024
- Satisfied Charges ₹ 3.89 M
as on 11-12-2024
- Revenue 59.39%
(FY 2020)
- Profit 227.83%
(FY 2020)
- Ebitda 68.73%
(FY 2020)
- Net Worth 49.76%
(FY 2020)
- Total Assets 53.31%
(FY 2020)
About Carewin Pharmaceuticals (Gujarat)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.94 M.
The company currently has active open charges totaling ₹1.30 Cr. The company has closed loans amounting to ₹3.89 M, as per Ministry of Corporate Affairs (MCA) records.
Dhirenkumar Patel and Ashishbhai Shah serve as directors at the Company.
- CIN/LLPIN
U65910GJ1995PTC026756
- Company No.
026756
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Carewin Pharmaceuticals (Gujarat) Private Limited offer?
Carewin Pharmaceuticals (Gujarat) Private Limited offers a wide range of products and services, including Common Disease Medicines, Nasal Drops, Eye Drops, Diclofenac, Diclofenac Sodium Injection, Anti Infective Drugs & Medicines, Malaria Medicine.
Who are the key members and board of directors at Carewin Pharmaceuticals (Gujarat)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhirenkumar Patel  | Director | 17-Jul-1995 | Current |
| Ashishbhai Shah | Director | 20-Apr-2011 | Current |
Financial Performance of Carewin Pharmaceuticals (Gujarat).
Carewin Pharmaceuticals (Gujarat) Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 59.39% increase. The company also saw a substantial improvement in profitability, with a 227.83% increase in profit. The company's net worth Soared by an impressive increase of 49.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Carewin Pharmaceuticals (Gujarat)?
In 2020, Carewin Pharmaceuticals (Gujarat) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 10 Sep 1998 | ₹2.50 M | Open |
Bank Of India Creation Date: 18 Sep 1997 | ₹6.50 M | Open |
Bank Of India Creation Date: 18 Jul 1996 | ₹4.00 M | Open |
How Many Employees Work at Carewin Pharmaceuticals (Gujarat)?
Unlock and access historical data on people associated with Carewin Pharmaceuticals (Gujarat), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Carewin Pharmaceuticals (Gujarat), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Carewin Pharmaceuticals (Gujarat)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
